Shenzhen Mindray Bio-Medical Electronics - The Future Performance Is Worth Looking Forward To
244 Views10 May 2021 09:04
The article analyzed Mindray in terms of industry characteristics of China medical device, investment logic, business prospects, insights on centralized procurement and potential risks of the Company.
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 6-minute read)
Discussions
(Paid Plans Only)
Top 5%
Xinyao (Criss) Wang
HK/China Healthcare Analyst (ex-Fosun Pharma)
Price Chart(Sign Up to Access)
- Investment Opportunities in China Medical Device Industry17 May 2021
- Microport Scientific (853.HK) - It Is a Good Time to See Some Concerns17 May 2021
- Pre-IPO Lepu Biopharma - There Are Still Many Uncertainties13 May 2021
- Autobio Diagnostics (603658.CH) - The Turning Point Is Quietly Approaching03 May 2021
- Jiangsu Hengrui Medicine (600276.CH) - Insights on Recent Pullback and Future Business Prospects19 Apr 2021
- Industry Report - Insights on China IVD Industry06 Jan 2021
x